Codiak BioSciences, Inc.
CDAKDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted in 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.52M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Codiak BioSciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CDAK is no longer listed, so this page shows Q1 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 27
- −13 vs. Q4 2022
- Shares held
- 8.69M
- −5.87M (−40.3%) vs. Q4 2022
- Total value
- $1.52M
- −$4.25M (−73.7%) vs. Q4 2022
- New holders
- 1
- 5 more added
- Sold out
- 14
- 9 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDAK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $0 |
| Q1 2023 | 27 | $1.52M |
| Q4 2022 | 40 | $5.76M |
| Q3 2022 | 48 | $13.6M |
| Q2 2022 | 49 | $33.9M |
| Q1 2022 | 62 | $86.5M |
| Q4 2021 | 51 | $145.6M |
| Q3 2021 | 56 | $223.6M |
| Q2 2021 | 52 | $259.9M |
| Q1 2021 | 47 | $187.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Codiak BioSciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 3,540,636 | $617.8K | 0.02% | 00.0% | Unchanged |
| Laurion Capital Management LP | 2,013,300 | $351.3K | 0.02% | 00.0% | Unchanged |
| FMR LLC | 897,078 | $156.5K | 0.00% | −3,708,515−80.5% | Reduced |
| University of Texas/Texas Am Investment Managment Co | 847,108 | $148.0K | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 580,770 | $101.3K | 0.00% | −242,966−29.5% | Reduced |
| Ensign Peak Advisors, Inc | 252,782 | $44.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 161,957 | $28.0K | 0.00% | −138,854−46.2% | Reduced |
| Forefront Analytics, LLC | 110,210 | $19.2K | 0.01% | +10,275+10.3% | Added |
| Parametrica Management Ltd | 65,098 | $11.0K | 0.02% | 00.0% | Unchanged |
| Bank of America Corp | 53,055 | $9.23K | 0.00% | +4,483+9.2% | Added |
| HRT Financial LP | 30,566 | $5.00K | 0.00% | +30,566 | New |
| HighTower Advisors, LLC | 20,328 | $4.00K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 21,826 | $3.81K | 0.00% | −140,045−86.5% | Reduced |
| Acadian Asset Management LLC | 23,915 | $3.00K | 0.00% | 00.0% | Unchanged |
| Pathstone Family Office, LLC | 17,000 | $2.97K | 0.00% | −13,000−43.3% | Reduced |
| Morgan Stanley | 15,334 | $2.67K | 0.00% | −1,717−10.1% | Reduced |
| Citadel Advisors LLC | 12,740 | $2.22K | 0.00% | −20,208−61.3% | Reduced |
| Virtu Financial LLC | 10,491 | $2.00K | 0.00% | −41,911−80.0% | Reduced |
| National Asset Management, Inc. | 10,000 | $1.75K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,165 | $1.00K | 0.00% | −18,497−72.1% | Reduced |
| Advisor Group Holdings, Inc. | 667 | $116 | 0.00% | +357+115.2% | Added |
| Wells Fargo & Company | 332 | $58 | 0.00% | +169+103.7% | Added |
| US Bancorp | 300 | $52 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 100 | $17 | 0.00% | +78+354.5% | Added |
| UBS Group AG | 91 | $16 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 50 | $9 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 79 | $0 | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −666,891−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −300,852−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −187,833−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −69,102−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −48,349−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −47,800−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −29,453−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −26,131−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −2,506−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −449−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −152−100.0% | Sold out |